All 'PI3Kα' Products

22 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information


PI3Kδ inhibitor
AMG319 is a potent and selective PI3Kδ inhibitor with IC50 of 18 nM, >47-fold selectivity over other PI3Ks. Phase 2.
A11099 SALE


PI3K inhibitor
AS-252424 is a potent inhibitor of PI3K with selectivity for the γ isoform. It inhibits human recombinant PI3Kγ, α, β, and δ with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.


PI3K Inhibitor
AS-605240 is an orally active inhibitor of PI3-kinase γ that inhibits human recombinant PI3Kγ, α, β, and δ in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.
A10112 SALE


PI3K inhibitor
AZD6482 is a PI3Kbeta inhibitor (IC50=0.021M) used in antithrombotic therapy.
A11766 SALE

BAY 80-6946 (Copanlisib)

PI3K inhibitor
BAY 80-6946 is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
A11328 SALE

BYL719 (Alpelisib)

PI3K Inhibitor
BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.


mTOR Inhibitor
CC-223 is a potent mTOR kinase inhibitor (IC50=16 nM), with >150-fold sensitivity over the related lipid kinase PI3K-alpha (IC50=4uM).


ATR inhibitor
ETP-46464 is a potent and selective inhibitor of ATR with IC50 of 25 nM.


PI3K inhibitor
GDC-0084 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
A11443 SALE


mTOR inhibitor
GDC-0349 is under evaluating the Safety and Tolerability in Patients with locally advanced or metastatic solid tumors or non hodgkin's lymphoma.
A10438 SALE


mTOR/PI3K Inhibitor
GSK1059615 is a potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3Kα (IC50 = 2 nM).
A13021 SALE


PI3K Inhibitor
HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis.
A13224 SALE

KU 0060648

DNA-PK inhibitor
KU0060648 is a potent and selective inhibitor of DNA-dependent protein kinase (DNA-PK), (IC50 = 8.6 nM); with 20-1000 fold selectivity for DNA-PK over other PIKKs and a panel of 60 kinases. KU-0060648 enhances HDR efficiency and attenuates NHEJ frequency.
A11162 SALE


PI3K inhibitor

NVP-BGT226, novel phosphoinositide 3-kinase/mTOR dual inhibitor, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo.

A10730 SALE


PI3K Inhibitor
PIK-90 is a synthetic phosphoinositide 3-kinase (PI3K) inhibitor with IC50 values (nM) of 11, 350, 18, and 58 for p110 α, β, γ and δ isoforms, low mTOR activity.


PI3K inhibitor
PKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
A11079 SALE

PKI-587 ( Gedatolisib )

PI3K/mTOR inhibitor
PKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-α,β,γ, δ isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.

TG 100713

PI3K inhibitor
TG 100713 is an inhibitor of PI3-kinase that inhibits endothelial cell proliferation.
A10922 SALE


PI3K Inhibitor
TG100-115 inhibits PI3K γ and -δ(IC50 values of 83 and 235 nM, respectively).
A12480 SALE


PI3K/mTOR inhibitor
VS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.

XL-147 (Pilaralisib)

PI3K Inhibitor
XL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases.
A11014 SALE


PI3K inhibitor
ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms.

22 Item(s)

per page

Set Descending Direction